Like many , I am disappointed in the agenda. Several have said that in spite of that announcement that we will still receive some guidance on the uplist even if it’s only through the Q&A. I hope so or we are going to have to tolerate more churning of millions of shares by Citadel and similar groups for another period of time. Historically this churning has resulted in a downward trend post cc even if the news is encouraging. In light of that fact, I am not surprised by anyone tapping out at 49 if they bought at 20. In my opinion the only thing that will break this manipulation of pps is a definitive timeline on the ipo. Vaccine and peptide news is fine and welcome but it does not separate us from the hundreds of other companies on a similar quest. Eye on the ball- and the ball is the IPO.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links